Century Therapeutics (IPSC) Interest Expenses (2020 - 2023)
Century Therapeutics (IPSC) posted quarterly Interest Expenses of $69.2 million for Q1 2026, up 17342.57% year-over-year from N/an in Q1 2025, and up 1154016.67% quarter-over-quarter from $6000.0 in Q4 2025.
Powered by 
Analysis
Century Therapeutics (IPSC) Interest Expenses (2020 - 2023) Analysis & Trends
Century Therapeutics (IPSC) has reported Interest Expenses for 7 consecutive years, with $69.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 17342.57% year-over-year to $69.2 million; the TTM figure through Mar 2026 stood at $69.2 million (up 5356.82% YoY), while the FY2025 annual figure was $1.0 million, down 99.48% from the prior year.
- Interest Expenses climbed to $69.2 million in Q1 2026 per IPSC's latest filing, from $6000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $192.2 million in Q4 2024 and bottomed at -$46000.0 in Q4 2023.
- Historically, Interest Expenses has averaged $34.2 million across 5 years, with a median of $514000.0 in 2023.
- Annual changes were most pronounced in 2023 — Interest Expenses plunged 114.84% — and 2024, when it soared 417989.13%.
- Century Therapeutics' Interest Expenses stood at $310000.0 in 2022, then slumped by 114.84% to -$46000.0 in 2023, then jumped by 417989.13% to $192.2 million in 2024, then tumbled by 100.0% to $6000.0 in 2025, then jumped by 1154016.67% to $69.2 million in 2026.
- Business Quant data shows IPSC's Interest Expenses at $69.2 million in Q1 2026, $6000.0 in Q4 2025, and $21.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Century Therapeutics | 440.37 Mn | 180.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 404,000.00 |
| Dec 31, 2022 | 413,000.00 |
| Sep 30, 2022 | 373,000.00 |
| Jun 30, 2022 | 330,000.00 |
| Mar 31, 2022 | 314,000.00 |
| Dec 31, 2021 | 321,000.00 |
| Sep 30, 2021 | 322,000.00 |
| Jun 30, 2021 | 318,000.00 |
| Mar 31, 2021 | 314,000.00 |
| Dec 31, 2020 | 322,000.00 |
| Sep 30, 2020 | 59,000.00 |